1383744-75-9

Upstream product

• 1383744-73-7 C₂₀H₂₃F₂N₇O₂S 
• 590-17-0 cyanomethyl bromide 
• 1103234-57-6 N-(3-amino-2,4-difluorophenyl)propane-1-sulfonamide 
• 1383744-72-6 C₂₅H₃₁F₂N₇O₄S 
• 1383745-23-0 C₉H₁₀F₂N₄O₂S 
• 3896-29-5 N-(2,6-difluorophenyl)acetamide 
• 25892-08-4 N-(2,6-difluoro-3-nitrophenyl)acetamide 
• 946826-47-7 N-(3-amino-2,6-difluorophenyl)acetamide 
• 1383745-37-6 N-(2,6-difluoro-3-(propylsulfonamido)phenyl)acetamide 

Relevant academic research and scientific papers

Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors

The present invention encompasses compounds of general formula (I) wherein the groups R2 to R4, A, X and m are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain compounds of this kind and their use as medicaments.

NEW TRIAZOLYLPHENYL SULFONAMIDES AS SERINE/THREONINE KINASE INHIBITORS

The present invention encompasses compounds of general formula (I) wherein the groups R2 to R4, A,X and m are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain compounds of this kind and their use as medicaments.